Literature DB >> 17713551

Clinical characteristics and outcomes in patients with t(8;21) acute myeloid leukemia in Japan.

H Narimatsu, T Yokozawa, H Iida, M Tsuzuki, M Hayakawa, T Takeo, M Iino, T Ichihashi, C Kato, A Sawamoto, H Sao, M Yanada, N Emi, H Kiyoi, T Yamaguchi, T Naoe, R Suzuki, I Sugiura.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17713551     DOI： 10.1038/sj.leu.2404905

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

Review 1.  Core binding factor acute myeloid leukemia: Advances in the heterogeneity of KIT, FLT3, and RAS mutations (Review).

Authors:  Xi Quan; Jianchuan Deng
Journal:  Mol Clin Oncol       Date:  2020-05-25

2.  Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan.

Authors:  Hiroto Narimatsu; Masaki Iino; Takuji Ichihashi; Toshiya Yokozawa; Masaya Hayakawa; Hitoshi Kiyoi; Takaaki Takeo; Akiyo Sawamoto; Hiroatsu Iida; Motohiro Tsuzuki; Masamitsu Yanada; Tomoki Naoe; Ritsuro Suzuki; Isamu Sugiura
Journal:  Int J Hematol       Date:  2008-06-17       Impact factor: 2.490

3.  Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications.

Authors:  Håkon Reikvam; Kimberley Joanne Hatfield; Astrid Olsnes Kittang; Randi Hovland; Øystein Bruserud
Journal:  J Biomed Biotechnol       Date:  2011-05-03

4.  High expression of c-kit mRNA predicts unfavorable outcome in adult patients with t(8;21) acute myeloid leukemia.

Authors:  Xiaoning Gao; Ji Lin; Li Gao; Ailing Deng; Xiaolin Lu; Yonghui Li; Lili Wang; Li Yu
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

5.  Epigenetic Silencing of Eyes Absent 4 Gene by Acute Myeloid Leukemia 1-Eight-twenty-one Oncoprotein Contributes to Leukemogenesis in t(8;21) Acute Myeloid Leukemia.

Authors:  Sai Huang; Meng-Meng Jiang; Guo-Feng Chen; Kun Qian; Hong-Hao Gao; Wei Guan; Jin-Long Shi; An-Qi Liu; Jing Liu; Bian-Hong Wang; Yong-Hui Li; Li Yu
Journal:  Chin Med J (Engl)       Date:  2016-06-05       Impact factor: 2.628

6.  Idarubicin plus behenoyl cytarabine and 6-thioguanine compares favorably with idarubicin plus cytarabine-based regimen for children with previously untreated acute myeloid leukemia: 10-year retrospective, multicenter study in Korea.

Authors:  Dae Hyoung Lee; Nak Gyun Chung; Bin Cho; Hack Ki Kim; Hyoung Jin Kang; Hee Young Shin; Hyo Seop Ahn; Keon Hee Yoo; Ki Woong Sung; Hong Hoe Koo; Hoon Kook; Tai Ju Hwang; Ho Joon Im; Jong Jin Seo; Hyeon Jin Park
Journal:  J Korean Med Sci       Date:  2009-12-26       Impact factor: 2.153
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.